Start Date
October 31, 2001
Primary Completion Date
May 31, 2004
Study Completion Date
May 31, 2004
bortezomib
Memorial Sloan-Kettering Cancer Center, New York
University of Chicago Cancer Research Center, New York
Albert Einstein College of Medicine, The Bronx
University of Colorado Cancer Center at University of Colorado Health Sciences Center, Aurora
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston
Abramson Cancer Center at University of Pennsylvania Medical Center, Philadelphia
National Cancer Institute (NCI)
NIH
Memorial Sloan Kettering Cancer Center
OTHER